DRKS00026785
Completed
未知
Children’s Health InterventionaL Trial III - CHILT III
Deutsche Sporthochschule Köln, Institut für Bewegungs- und Neurowissenschaften, Abteilung Bewegungs- und Gesundheitsförderung0 sites134 target enrollmentOctober 13, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- E65-E68
- Sponsor
- Deutsche Sporthochschule Köln, Institut für Bewegungs- und Neurowissenschaften, Abteilung Bewegungs- und Gesundheitsförderung
- Enrollment
- 134
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children aged 8\- including 16 years and their parents.
- •\-The participant's BMI exceeds the 97th percentile and/or either a) obesity\-associated risk factors or b) obesity\-associated diseases are present
- •\-Sufficient German language skills of the children and parents
- •\-Sufficient motivation of the children and parents to actively participate in the training course.
- •\-Normal ability to attend school
- •\-The previous outpatient medical treatment according to the currently available guideline recommendation (e.g. AGA) was unsuccessful.
Exclusion Criteria
- •\-Psychological disorder or illness (e.g. eating disorder, bulimia).
- •\-lack of motivation on the part of the children or their parents
- •\-Inadequate group ability
- •\-Adiposity due to a medical condition (e.g., Prader\-Willi syndrome)
- •\-lack of written consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A nutrition intervention research project for low-income mothers of toddlersObesityDiet and Nutrition - ObesityACTRN12610000981022Susan Baker600
Active, not recruiting
Not Applicable
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 14.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2012-001055-39-ESSanofi Pasteur SA795
Active, not recruiting
Not Applicable
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 17.0Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2012-001055-39-CZSanofi Pasteur SA795
Active, not recruiting
Not Applicable
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 17.0Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2012-001055-39-DESanofi Pasteur SA795
Active, not recruiting
Not Applicable
Antibody Persistence in Healthy South African Children After Primary Series and Booster Vaccination with an Investigational(DTaP-IPV-Hep B-PRP-T) or Control VaccinesPrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infections caused by hepatitis B virusMedDRA version: 14.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2011-004450-26-Outside-EU/EEASanofi Pasteur SA567